Fluoxetine | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Physical properties [] | |
---|---|
Molecular mass | 309.33 g/mol [1] |
Melting point | 179 - 182 °C [1] |
Boiling point | 395.1°C at 760 mmHg [1] |
Solubility | insoluble [1] |
Predicted LogP | 4 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C17H18F3NO [1] |
IUPAC name | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine [1] |
SMILES | CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F [1] |
InChI | InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3 [1] |
InChIKey | RTHCYVBBDHJXIQ-UHFFFAOYSA-N [1] |
Fluoxetine
Fluoxetine (also known as Fluoxetina, Animex-On, Fluoxetin, Fluval, Fluoxetinum, Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine, N-Methyl-γ-(4-(trifluoromethyl)phenoxy)benzenepropanamine, N-Methyl-3-phenyl-3-((α,α,α-trifluoro-p-tolyl)oxy)propylamine, Benzenepropanamine, N-methyl-γ-(4-(trifluoromethyl)phenoxy)-, (+-)- or n-methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine) is a serotonin reuptake inhibitor substance of the phenylpropylamine class.
Chemistry
Stereochemistry []
Fluoxetine is a racemic mixture of the enantiomers
Stereoisomers |
---|
Anodyne Usernotes [] | |
---|---|
0xea / Fluoxetine via | noted acute effects; long term no notable improvement in quality of life; slight potenciation of lisdexamphetamine through CYP2D6 inhibition |
Experience reports []
There are currently 6 experience reports involving fluoxetine on OpenErowid:
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3386, Fluoxetine. Accessed August 2, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/3386